The developer of a toolkit that promises to create a "digital twin" of individuals with chronic metabolic diseases like diabetes to help model the impact of lifestyle changes has secured $1
A drug originally developed for high blood pressure could find a new use in the treatment of Huntington's disease, thanks to an artificial intelligence-based drug discovery programme at Spa
Sonde Health has launched a new version of its vocal biomarker technology – which aims to diagnose diseases from a person's voice patterns – that it says can be used to monitor mental healt
Exscientia's artificial intelligence-based drug discovery engine is still largely unproven, but that hasn't stopped the company raking in funding from investors keen to back its platform.
Digital health tools hold huge potential, and the evidence base is growing all the time – so what is holding us back and how does the sector overcome the multiple barriers to widespread ado
